Coya Therapeutics names Mark H. Pavao to Audit Committee, filling four-member panel
Four members now compose the Audit Committee of Coya Therapeutics, Inc. (Nasdaq: COYA) after the board voted August 6, 2026 to seat director Mark H. Pavao as the fourth, per an 8-K/A filed with the Securities and Exchange Commission on…
By Kwame Asante·Aug 9, 2026·2 min read·regulatory·COYA
Source: sec.gov
© 2026 NewsMeter
RegulatorySep 19, 2026
Thirty years on air, Fox News anchor Trace Gallagher says the hardest parenting skill is knowing when to stop talking
2 min
Regulatory · AMZNSep 19, 2026
Philadelphia serial killer case: more than one million evidence items, snuff film network feared
2 min
Regulatory · SOBRSep 18, 2026
SOBR Safe voids Clean World Ventures merger, to pull Form S-4
1 min